Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Se-Jin Sung"
Filter
Filter
Article category
Keywords
Publication year
Authors
Display
Original Articles
Neutrophil to Lymphocyte Ratio: A Predictive Marker for Treatment Outcomes in Patients With Rectal Cancer Who Underwent Neoadjuvant Chemoradiation Followed by Surgery
Byong Ho Jeon, Ui Sup Shin, Sun Mi Moon, Jung Il Choi, Mi-Sook Kim, Kie Hwan Kim, Se-Jin Sung
Ann Coloproctol. 2019;35(2):100-106.   Published online April 30, 2019
DOI: https://doi.org/10.3393/ac.2018.10.01
  • 7,016 View
  • 135 Download
  • 20 Web of Science
  • 21 Citations
AbstractAbstract PDF
Purpose
In this study, we investigated the role of neutrophil to lymphocyte ratio (NLR) as a predictor of tumor response and as a prognostic factor in patients with rectal cancer who had undergone curative surgery after neoadjuvant chemoradiation therapy (nCRT).
Methods
Between January 2009 and July 2016, we collected 140 consecutive patients who had undergone curative intent surgery after nCRT due to rectal adenocarcinoma. We obtained the pre- and post-nCRT NLR by dividing the neutrophil count by the lymphocyte count. The cutoff value was obtained using receiver operating characteristic analysis for tumor response and using maximally selected rank analysis for recurrence-free survival (RFS). The relationship among NLR, tumor response, and RFS was assessed by adjusting the possible clinico-pathological confounding factors.
Results
The possibility of pathologic complete response (pCR) was significantly decreased in high pre- (>2.77) and postnCRT NLR (>3.23) in univariate regression analysis. In multivariate analysis, high post-nCRT NLR was an independent negative predictive factor for pCR (adjusted odds ratio, 0.365; 95% confidence interval [CI], 0.145–0.918). The 5-year RFS of all patients was 74.6% during the median 37 months of follow-up. Patients with higher pre- (>2.66) and post-nCRT NLR (>5.21) showed lower 5-year RFS rates (53.1 vs. 83.3%, P = 0.006) (69.2 vs. 75.7%, P = 0.054). In multivariate Cox analysis, high pre-nCRT NLR was an independent poor prognostic factor for RFS (adjusted hazard ratio, 2.300; 95% CI, 1.061–4.985).
Conclusion
Elevated NLR was a negative predictive marker for pCR and was independently associated with decreased RFS. For confirmation, a large-scale study with appropriate controls is needed.

Citations

Citations to this article as recorded by  
  • Recurrence risk following rectal cancer surgery: a survival analysis of key predictors
    Neda Gorjizadeh, Reza Hajebi, Matin Vahedi, Mahsa Mottahedi, Elham Nazar
    Japanese Journal of Clinical Oncology.2025; 55(8): 880.     CrossRef
  • Circulating Markers of Systemic Inflammation, Measured After Completion of Neoadjuvant Therapy, Associated With Response in Locally Advanced Rectal Cancer
    Ross K. McMahon, Sean M. O’Cathail, Colin W. Steele, Harikrishnan S. Nair, Jonathan J. Platt, Donald C. McMillan, Paul G. Horgan, Campbell S. Roxburgh
    Diseases of the Colon & Rectum.2025; 68(6): 713.     CrossRef
  • Response Prediction to Neoadjuvant Chemoradiotherapy in Rectal Cancer Based on Systemic Inflammatory Markers (NLR, PLR, and LMR)
    Roger Beltrati Coser, Caio Sergio R. Nahas, Alex Jones Flores Cassenote, Omar S. T. Ghani, Rafaela B. B. Pinheiro, Sergio Carlos Nahas, Carlos Frederico S. Marques
    Journal of Gastrointestinal Cancer.2025;[Epub]     CrossRef
  • Prognostic Value of Dynamic Changes in Immune-Inflammatory and Tumor Biomarkers Following Chemoradiotherapy in Locally Advanced Rectal Cancer
    Mahmoud Al-Masri, Yasmin Safi, Mohammad Almasri, Ramiz Kardan, Daliana Mustafa, Osama Alayyan, Bilal Kahalah, Rama AlMasri
    Cancers.2025; 17(20): 3383.     CrossRef
  • Hematological markers as prognostic predictors in patients undergoing colon cancer surgery
    Jessica Patricia Gonzales Stuva, Carlos Pérez-López, Marcelo Sebastian Ramírez Romero, Ana Bernabeu García, Pamela Vivas Angeles, Diana Escolà Ripoll, Sandra López Gordo
    Scientific Reports.2025;[Epub]     CrossRef
  • Landscape of Biomarkers and Pathologic Response in Rectal Cancer: Where We Stand?
    Abrahams Ocanto, Macarena Teja, Francesco Amorelli, Felipe Couñago, Ariel Gomez Palacios, Diego Alcaraz, Ramón Cantero
    Cancers.2024; 16(23): 4047.     CrossRef
  • Prognostic role of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte, and lymphocyte-to-monocyte ratio in operated rectal cancer patients: systematic review and meta-analysis
    Giuseppe Portale, Patrizia Bartolotta, Danila Azzolina, Dario Gregori, Valentino Fiscon
    Langenbeck's Archives of Surgery.2023;[Epub]     CrossRef
  • NEUTROPHIL-LYMPHOCYTE RATIO (NLR) AND LYMPHOPENIAAS PROGNOSTIC FACTORS OF OVERALL SURVIVAL IN LOCALADVANCED RECTAL CANCER
    Ocanto A, Morera R, Rodríguez I, Cantero R
    INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH.2023; : 11.     CrossRef
  • Neutrophil-to-lymphocyte ratio predicts survival of patients with rectal cancer receiving neo-adjuvant chemoradiation followed by radical resection: a meta-analysis
    Giuseppe Colloca, Antonella Venturino, Domenico Guarneri
    Expert Review of Anticancer Therapy.2023; 23(4): 421.     CrossRef
  • Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy
    Tzu-Chieh Yin, Po-Jung Chen, Yung-Sung Yeh, Ching-Chun Li, Yen-Cheng Chen, Wei-Chih Su, Tsung-Kun Chang, Ching-Wen Huang, Chun-Ming Huang, Hsiang-Lin Tsai, Jaw-Yuan Wang
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • The Crying Need for a Better Response Assessment in Rectal Cancer
    Samuel Amintas, Nicolas Giraud, Benjamin Fernandez, Charles Dupin, Quentin Denost, Aurelie Garant, Nora Frulio, Denis Smith, Anne Rullier, Eric Rullier, Te Vuong, Sandrine Dabernat, Véronique Vendrely
    Current Treatment Options in Oncology.2023; 24(11): 1507.     CrossRef
  • Prognostic Role of Peripheral Neutrophil-Lymphocyte Ratio (NLR) and Platelet-Lymphocyte Ratio (PLR) in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
    Şefika Arzu Ergen, Ceren Barlas, Cumhur Yıldırım, Didem Çolpan Öksüz
    Journal of Gastrointestinal Cancer.2022; 53(1): 151.     CrossRef
  • Deep regional hyperthermia combined with modern concurrent chemoradiotherapy increases T-downstaging rate in locally advanced rectal cancer
    Yuxia Wang, Siyi Lu, Yuxia Shao, Ran Peng, Xuemin Li, Junjie Wang, Hao Wang
    International Journal of Hyperthermia.2022; 39(1): 431.     CrossRef
  • High Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Low Lymphocyte Levels Are Correlated With Worse Pathological Complete Response Rates
    Serdar Karakaya, İbrahim Karadağ, Mehmet Emin Yılmaz, Ömür Berna Çakmak Öksüzoğlu
    Cureus.2022;[Epub]     CrossRef
  • Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer
    Sanghyun An, Hongjin Shim, Kwangmin Kim, Bora Kim, Hui-Jae Bang, Hyejin Do, Hyang-Rae Lee, Youngwan Kim
    Annals of Coloproctology.2022; 38(2): 97.     CrossRef
  • Watch and wait strategies for rectal cancer: A systematic review
    In Ja Park
    Precision and Future Medicine.2022; 6(2): 91.     CrossRef
  • Histopathological and Haemogram Features Correlate with Prognosis in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation without Pathological Complete Response
    Yu-Ming Huang, Hsi-Hsien Hsu, Chien-Kuo Liu, Ching-Kuo Yang, Po-Li Tsai, Tzu-Yin Tang, Shih-Ming Hsu, Yu-Jen Chen
    Journal of Clinical Medicine.2022; 11(17): 4947.     CrossRef
  • Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: A systematic review and meta-analysis
    Hytham K.S. Hamid, George N. Davis, Mario Trejo-Avila, Patrick O. Igwe, Andrés Garcia-Marín
    Surgical Oncology.2021; 37: 101556.     CrossRef
  • The prognostic utility of pre‐treatment neutrophil‐to‐lymphocyte‐ratio (NLR) in colorectal cancer: A systematic review and meta‐analysis
    Mate Naszai, Alina Kurjan, Timothy S. Maughan
    Cancer Medicine.2021; 10(17): 5983.     CrossRef
  • Predictive Ability of Neutrophil-Lymphocyte Ratio in Determining Tumor Staging in Colorectal Cancer
    Chirag Pereira, Jiju Mohan, Shankar Gururaj, Prajwal Chandrashekhara
    Cureus.2021;[Epub]     CrossRef
  • An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma
    Yanwu Sun, Zhekun Huang, Pan Chi
    International Journal of Clinical Oncology.2020; 25(7): 1299.     CrossRef
Is the Location of the Tumor Another Prognostic Factor for Patients With Colon Cancer?
Myung-Kyu Jung, Ui Sup Shin, Young-Jun Ki, Yong-Bae Kim, Sun-Mi Moon, Se-Jin Sung
Ann Coloproctol. 2017;33(6):210-218.   Published online December 31, 2017
DOI: https://doi.org/10.3393/ac.2017.33.6.210
  • 6,366 View
  • 94 Download
  • 16 Web of Science
  • 16 Citations
AbstractAbstract PDF
Purpose

In this study, we investigated both the characteristics of right colon cancer (RTCC) in comparison with those of left colon cancer (LTCC) and the impact of the location of the colon cancer on the prognosis.

Methods

We retrospectively analyzed the cases of 974 patients with nonmetastatic colon cancer who had undergone surgery with a curative intent from January 2001 to December 2011. RTCC was defined as a tumor located proximal to the splenic flexure. The characteristics of RTCC cancer were investigated by using descriptive analyses, and their impacts on the prognosis were assessed by using a Cox multivariate regression.

Results

Compared to LTCC, RTCC showed a female-dominant feature, and an undifferentiated pathology was more frequently observed. The number of lymph nodes retrieved from patients with RTCC was significantly higher than that retrieved from patients with LTCC. During 75 months of follow-up, peritoneal recurrence was more common in patients with RTCC than it was in patients with LTCC, and among the patients with stage III colon cancer, the disease-free and the overall survival rates were significantly worse in patients with RTCC. After adjustments with the other prognostic factors associated with colon cancer had been made, a tumor located at the right colon was found to be independently associated with poor prognosis.

Conclusion

RTCC showed unique clinicopathologic features and was associated with a poorer prognosis.

Citations

Citations to this article as recorded by  
  • Differences in the expression of CMTM3 and SSTR2 genes in right and left colon tumors: A molecular insight into colorectal cancer
    Tuğçe Binen, Etem Akbaş, Tahsin Çolak, Tuba Kara, Aslıhan Bakır, Badel İnce
    Medical Oncology.2025;[Epub]     CrossRef
  • The relationship between clinical and pathological findings and FDG - PET uptake in metastatic colorectal cancers
    Bediz Kurt İnci, Fatih Gürler, Osman Sütcüoğlu, Gözde Tahtacı, Aytuğ Üner, Ahmet Özet, Nazan Günel, Ozan Yazıcı
    Indian Journal of Cancer.2024; 61(3): 440.     CrossRef
  • Splenic flexure cancer survival: a 25‐year experience and implications for complete mesocolic excision (CME) and central vascular ligation (CVL)
    Krishanth Naidu, Pierre H. Chapuis, Kilian G. M. Brown, Charles Chan, Matthew J. F. X. Rickard, Kheng‐Seong Ng
    ANZ Journal of Surgery.2023; 93(7-8): 1861.     CrossRef
  • Prognostic Significance of MRE11 Overexpression in Colorectal Cancer Patients
    Vincent Ho, Liping Chung, Kate Wilkinson, Vivienne Lea, Stephanie H. Lim, Askar Abubakar, Weng Ng, Mark Lee, Tara L. Roberts, Wei Chua, Cheok Soon Lee
    Cancers.2023; 15(9): 2438.     CrossRef
  • Colorectal Cancer: Disease Process, Current Treatment Options, and Future Perspectives
    Amusa S. Adebayo, Kafilat Agbaje, Simeon K. Adesina, Oluwabukunmi Olajubutu
    Pharmaceutics.2023; 15(11): 2620.     CrossRef
  • Intertwined leukocyte balances in tumours and peripheral blood as robust predictors of right and left colorectal cancer survival
    Ramón Cantero-Cid, Karla Marina Montalbán-Hernández, Jenny Guevara, Alejandro Pascual-Iglesias, Elisa Pulido, José Carlos Casalvilla, Cristóbal Marcano, Cristina Barragán Serrano, Jaime Valentín, Gloria Cristina Bonel-Pérez, José Avendaño-Ortiz, Verónica
    World Journal of Gastrointestinal Oncology.2022; 14(1): 295.     CrossRef
  • Disparities in Healthcare: Evaluation of Equity in Access to Surveillance Colonoscopy After Hemicolectomy in Patients With Colon Cancer During the COVID-19 Pandemic
    Ranbir Singh, Eshan Patel
    Cureus.2022;[Epub]     CrossRef
  • Comparison of prolonged postoperative ileus between laparoscopic right and left colectomy under enhanced recovery after surgery: a propensity score matching analysis
    Zhenmeng Lin, Chunkang Yang, Yi Wang, Mingfang Yan, Huizhe Zheng
    World Journal of Surgical Oncology.2022;[Epub]     CrossRef
  • The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status
    Georgios Antonios Margonis, Neda Amini, Stefan Buettner, Yuhree Kim, Jaeyun Wang, Nikolaos Andreatos, Doris Wagner, Kazunari Sasaki, Andrea Beer, Carsten Kamphues, Daisuke Morioka, Inger Marie Løes, Katsunori Imai, Jin He, Timothy M. Pawlik, Klaus Kaczire
    Annals of Surgery.2021; 273(6): 1165.     CrossRef
  • Are right-sided colectomies for neoplastic disease at increased risk of primary postoperative ileus compared to left-sided colectomies? A coarsened exact matched analysis
    Richard Garfinkle, Faisal Al-Rashid, Nancy Morin, Gabriela Ghitulescu, Julio Faria, Carol-Ann Vasilevsky, Marylise Boutros
    Surgical Endoscopy.2020; 34(12): 5304.     CrossRef
  • Prognostic Heterogeneity of MRE11 Based on the Location of Primary Colorectal Cancer Is Caused by Activation of Different Immune Signals
    Chuan-Wen Fan, Maria Kopsida, You-Bin Liu, Hong Zhang, Jing-Fang Gao, Gunnar Arbman, Si-Yu-Wei Cao, Yuan Li, Zong-Guang Zhou, Xiao-Feng Sun
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Early Outcome of Enhanced Recovery Programs Versus Conventional Perioperative Care in Elective Open Left Side Colonic Carcinoma Surgery: Analysis of 80 Cases
    Emad M. Abd ElRahman, Mohamed S. Kharoub, Ahmed Shora, Nabil A. Emara, M. Ashraf Balbaa
    Indian Journal of Surgical Oncology.2020; 11(3): 372.     CrossRef
  • Evaluating the distribution of the locations of colorectal cancer after appendectomy and cholecystectomy
    Szabolcs Ábrahám, Tibor Németh, Ria Benkő, Mária Matuz, Aurél Ottlakán, Dániel Váczi, Attila Paszt, Zsolt Simonka, György Lázár
    World Journal of Surgical Oncology.2020;[Epub]     CrossRef
  • Diagnostic and pathologic value of programmed death-ligand 1 expression in colonic carcinoma
    DinaO Helmy, MahmoudT El-Sabah Hussein, MohamedS Negm, MinaE Onsy
    Egyptian Journal of Pathology.2020; 40(2): 204.     CrossRef
  • Differences Regarding the Molecular Features and Gut Microbiota Between Right and Left Colon Cancer
    Kwangmin Kim, Ernes John T. Castro, Hongjin Shim, John Vincent G. Advincula, Young-Wan Kim
    Annals of Coloproctology.2018; 34(6): 280.     CrossRef
  • Laterality: Right-Sided and Left-Sided Colon Cancer
    Seong Kyu Baek
    Annals of Coloproctology.2017; 33(6): 205.     CrossRef
  • FirstFirst
  • PrevPrev
  • Page of 1
  • Next Next
  • Last Last

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP